Skip to content

Multi-center clinical trials of Reduning Injection on Treating AECOPD

Multi-center Randomzed controlled Open clinical trial of Reduning Injection on Treating AECOPD inpatients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003160
Enrollment
Unknown
Registered
2013-03-12
Start date
2013-03-12
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AECOPD

Interventions

Reduning Treatment group:Reduning Injection add convntional therapy
control group:convntional therapy

Sponsors

The Chinese People's Liberation Army General Hospital of Beijing Military Area
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged beyong 18 years old; 2. The patient With a history of COPD,and the respiratory function detection index as diagnostic basis; 3. AECOPD meet the diagnostic criteria of the 2007 Chinese Society of Respiratory Diseases Society of the COPD disease treatment guidelines; 4. Temperature is beyond 38 degree C; 5. The patient who has signed the ICF.

Exclusion criteria

Exclusion criteria: 1. The patient who is allergy to Reduning Injection; 2. The patient with diseases of the immune system; 3. The patient whose illness are combined with serious liver and kidney disease; 4. The patient who has pulmonary heart disease; 5. The patient whose PaCO2 is beyond 80mmHg; 6. The patient who has cardiovascular disease with serious complications; 7. The patient with cerebral apoplexy; 8. Pregnant woman.

Design outcomes

Primary

MeasureTime frame
temperature;clinical syndrome (fever cough sputum dyspnea);

Countries

China

Contacts

Public ContactXuezhong Yu
yxz@medmail.com.cn+86 13601262164

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026